Canada Competition Bureau issues No Action Letter for WELL Health’s acquisition of HEALWELL AI

The Commissioner of Competition concluded the review of WELL Health Technologies Corp.’s purchase of a majority stake in HEALWELL AI Inc. and issued a No Action Letter on October 22, 2026. The acquisition, completed on April 1, 2025, also included HEALWELL’s concurrent purchase of Orion Health. Both companies cooperated with the Bureau, which had obtained a Federal Court order for records in December 2025.

The letter removes regulatory uncertainty, allowing WELL and HEALWELL to proceed with integration and strategic plans without the risk of a Competition Act challenge.

  • 1The Competition Bureau issued a No Action Letter on October 22, 2026, indicating no intent to apply section 92 of the Competition Act to the transaction.
  • 2WELL Health’s acquisition of a controlling interest in HEALWELL was completed on April 1, 2025.
  • 3The transaction also included HEALWELL’s acquisition of Orion Health.
  • 4The Bureau obtained a Federal Court order for the production of records in December 2025.
  • 5Both WELL and HEALWELL cooperated fully with the Bureau throughout the review.

Sources